Red Tortoise LLC’s ALX Oncology ALXO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-340
Closed -$4.18K 573
2024
Q1
$3.79K Hold
340
﹤0.01% 389
2023
Q4
$5.06K Hold
340
﹤0.01% 294
2023
Q3
$1.63K Buy
340
+24
+8% +$130 ﹤0.01% 483
2023
Q2
$2.37K Buy
+316
New +$2.07K ﹤0.01% 424
2023
Q1
Sell
-196
Closed -$2.21K 560
2022
Q4
$2.21K Buy
+196
New +$2.2K ﹤0.01% 453
2021
Q4
Sell
-196
Closed -$2K 91
2021
Q3
$2K Buy
+196
New +$13.1K ﹤0.01% 396

Other funds holding ALXO

Red Tortoise LLC's ALXO Position: Q2 2024 in Review

Red Tortoise LLC sold out of ALX Oncology (ALXO) in Q2 2024, closing a stake of 340 shares — an estimated $4.18K sold.

Red Tortoise LLC first reported a position in ALXO in Q3 2021 and held it in 6 quarters. The position peaked at $5.06K in Q4 2023. 111 funds tracked by Wall St. Rank hold ALXO as of Q2 2024.

  • Red Tortoise LLC reported no remaining ALX Oncology position as of Q2 2024 after selling out during the quarter.
  • Red Tortoise LLC sold 340 ALX Oncology shares in Q2 2024, an estimated $4.18K.
  • Red Tortoise LLC first reported a position in ALX Oncology in Q3 2021 and held it in 6 quarters.
  • Red Tortoise LLC's ALX Oncology position peaked at $5.06K in Q4 2023.
  • 111 funds tracked by Wall St. Rank held ALX Oncology as of Q2 2024.

Based on Red Tortoise LLC's 13F filing for Q2 2024, filed 31 Jul 2024.